A universal vaccine has been described as the ‘holy grail’ – but how close are we to getting one?
- Visiting Research Fellow, History of Biomedical Sciences, University of Cambridge
This lab-designed antibody treatment can treat COVID-19 and block infection, though its cost means it may be reserved for the most vulnerable.
It takes around 61 hours to identify the pathogen causing a patient’s pneumonia. A new test reduces that to four hours.
Scientists at Cambridge are developing a lab-in-a-briefcase for rapidly and cheaply identifying disease-causing bacteria.
Vaccines and antivirals aren’t the only game in town.
Despite predictions, the CRISPR/Cas9 gene editing technique didn’t win the Nobel Prize. But with the technology nevertheless taking off, it is time we start having an informed public debate about it.
While many of the fruits of the human genome project could be decades away, DNA sequencing of drug-resistant bacteria has been striding forwards
Most people have never heard of them, but monoclonal antibodies have transformed medicine in the 40 years since their discovery.
Contact Lara for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Sevenoaks, United Kingdom
- Website
- X (formerly Twitter): @biomedhistories
- Article Feed
- Joined
